LMR Partners’s 4D Molecular Therapeutics FDMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-487,533
Closed -$15.5M 780
2024
Q1
$15.5M Buy
+487,533
New +$15.5M 0.16% 74